Health
What have we learned about accelerating drug development from Covid-19? – MedCity News
This pandemic has shown that collaboration, biosimulation and decentralized trials, and active preparedness programs lead to…
In response to Covid-19, the global drug development community has moved faster and further than ever before. But what have we learned from meeting this emergency? Players throughout the ecosystem, from drug developers to regulators, are considering how…
Continue Reading